Delivery Order 75N93019D00016-75N93021F00001
Award Date
8/16/21
Potential Completion Date
8/15/22
Potential Value
$595K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35233, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB), an internationally renowned research university and academic medical center. The contract, valued at $616,373.16, is a Firm Fixed Price Delivery Order under the "In Vitro Assessments of Antimicrobial Activity (IVAAA)" master IDIQ contract. The objective is to determine the...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a Delivery Order contract to the University of Alabama at Birmingham (UAB) to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses. The contract is a Firm Fixed Price type awarded under the larger In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery Contract (IDC). The contract has a ceiling value of $548,829.16 and a...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Alabama at Birmingham (UAB) to provide a "SUPPLEMENT TO COMPREHENSIVE PANEL FOR VIRUSES". The $26,500.00 Firm Fixed Price contract was awarded on March 24, 2015 as a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC). The contract has no set-aside designation. As a leading...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $978,590.76 Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB) on August 15, 2014 for a "Comprehensive Panel for Viruses" requirement. This Delivery Order was placed under NIAID's In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery, Indefinite Quantity (IDIQ) contract and had a completion date of September 29, 2015. UAB, a public research university and academic...
The University of Alabama at Birmingham (UAB) was awarded a $560,418.16 Firm Fixed Price Delivery Order contract by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract is for the provision of a Comprehensive Viral Screening Panel and is part of the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of December 15,...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to conduct targeted clinical research addressing select viral infections. The $11,514,985.14 definitive contract has a completion date of February 28, 2026 and does not utilize any set-aside designation. As the prime contractor, UAB will be responsible for participating in protocol...
This delivery order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in Groups 1, 2, and 3, as well as other rapidly emerging viruses that utilize the same assay methodology. The $586,919.16 contract was issued under the In Vitro Assessments of Antimicrobial Activity master...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to provide in vitro assessments for antimicrobial activity. The contract, valued at $12,178, is a delivery order under the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) vehicle. The award has a completion date of November 14, 2013,...